无眩晕急性低音调听力损失的预后:范围综述
本范围综述检索MEDLINE、Embase和Scopus,纳入41项研究,评估无眩晕急性低音调听力损失(ALHL)患者的听力恢复、复发和/或波动及进展为梅尼埃病(MD)的情况。多数队列(40项中39项)报告多数(>50%)患者听力部分或完全恢复,复发较常见,进展为MD不常报告;8项研究中6项显示症状出现至治疗时间较短预测听力结局较好。
要点
- 多数无眩晕ALHL患者听力部分或完全恢复,但复发和/或波动较常见。
- 进展为梅尼埃病不常报告,仅见于少数患者。
- 8项研究中6项显示症状出现至治疗时间较短预测听力结局较好。
核心结论
- 文献提示多数无眩晕ALHL患者听力改善,但复发和/或波动常见,进展为MD见于少数患者。
- 需要采用标准化纳入和结局标准的额外试验来确定ALHL的理想治疗。
研究设计与样本
- 范围综述,检索MEDLINE、Embase和Scopus(2020年5月14日和2022年7月6日),纳入41项研究,由两名评价者评估纳入并提取数据,分歧由第三名评价者裁定。
主要发现
- 研究间在ALHL定义、治疗方法和随访时间方面存在广泛异质性。
- 多数队列(40项中39项)报告多数(>50%)患者听力部分或完全恢复,复发报告相对常见。
- 进展为MD不常报告。
- 8项研究中6项显示症状出现至治疗时间较短预测听力结局较好。
局限性
- 研究间在ALHL定义、治疗方法和随访时间方面存在广泛异质性。
- 需要采用标准化纳入和结局标准的额外试验来确定ALHL的理想治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Despite its relatively high prevalence, our understanding of the natural clinical course of acute low-tone hearing loss (ALHL) without vertigo remains incomplete. The purpose of this study is to summarize the findings of studies that evaluated recovery from hearing loss (HL), recurrence and/or fluctuation of HL, and progression to Meniere's Disease (MD) of patients presenting with ALHL without vertigo. METHODS: A scoping review of the English literature was performed. On May 14, 2020 and July 6, 2022, MEDLINE, Embase, and Scopus were searched to identify articles related to the prognosis of ALHL. To be included, articles had to present outcomes that were clearly distinguishable for patients with ALHL without vertigo. Two reviewers evaluated articles for inclusion and extracted data. Disagreements were adjudicated by a third reviewer. RESULTS: Forty-one studies were included. There was extensive heterogeneity between studies in regard to defining ALHL, treatment methods, and time of follow-up. Most of the cohorts (39 out of 40) reported partial or complete recovery of hearing in the majority (>50%) of patients, although reports of recurrence were relatively common. Progression to MD was infrequently reported. Shorter time from onset of symptoms to treatment predicted better hearing outcomes in 6 of 8 studies. CONCLUSION: The literature suggests that although the majority of patients with ALHL experience hearing improvement, recurrence and/or fluctuation are common, and progression to MD occurs in a minority of patients. Additional trials utilizing standardized inclusion and outcome criteria are needed to determine the ideal treatment for ALHL. LEVEL OF EVIDENCE: NA Laryngoscope, 133:2457-2469, 2023.
引用
- Huang RJ, Del Risco A, Riska KM, et al. Prognosis of Acute Low-Tone Hearing Loss Without Vertigo: A Scoping Review. Laryngoscope. 2023. PMID: 36880419. doi:10.1002/lary.30630
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。